No matter how you slice it, the GSK-NVS oncology transfer is a peculiar transaction. Andrew Witty’s quote in #msg-101017680 doesn’t pass the sniff test, but I suppose it makes a good CNBC soundbite.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”